Isabel Puig Borreil

Isabel Puig Borreil, PhD, is a Senior Investigator at Vall d'Hebron Institute of Oncology (VHIO) since September 2009, specializing in Stem Cells and Cancer under the guidance of Principal Investigator Héctor G Palmer, PhD. In addition, Isabel co-founded Oniria Therapeutics in March 2022, serving as a Scientific Advisor focusing on new therapeutic targets. Prior experience includes postdoctoral research at Institut Curie from July 2005 to July 2009, working on the Normal and Pathological Development of Melanocytes under Lionel Larue, PhD, and a PhD student at Instituto Hospital del Mar de Investigaciones Médicas (IMIM) from September 1999 to June 2005, exploring mechanisms of tumorigenesis under Antonio García de Herreros, PhD. Isabel holds a PhD in Health and Life Sciences from Universitat Pompeu Fabra (2005) and a Master's degree in the same field from the same institution (2002), as well as a Bachelor's degree in Biology with a specialization in Biomedicine from Universitat de Barcelona (2000).